Literature DB >> 17576013

Flow cytometry in myelodysplastic syndromes: report from a working conference.

Michael R Loken1, Arjan van de Loosdrecht, Kiyoyuki Ogata, Alberto Orfao, Denise A Wells.   

Abstract

Since new therapeutic strategies are emerging in myelodysplastic syndromes (MDS), a refined diagnostic procedure of the several subgroups of MDS is of increased importance. Multidimensional flow cytometry may add significantly to a more detailed analysis of the hematopoietic lineages with respect to qualification and quantification of bone marrow cells and is described in detail. Clearly defined aberrancies on myeloid immature and maturing cells are now identified with possible impact on diagnosis, classification and prognostication in the near feature.

Entities:  

Mesh：

Year:  2007        PMID： 17576013     DOI： 10.1016/j.leukres.2007.04.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  17 in total

1.  Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

Authors:  Michael R Loken; Todd A Alonzo; Laura Pardo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Phoenix A Ho; Janet Franklin; Todd M Cooper; Alan S Gamis; Soheil Meshinchi
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.

Authors:  Alex F Sandes; Mihoko Yamamoto; Sergio Matarraz; Maria de Lourdes L F Chauffaille; Sandra Quijano; Antonio López; Tsutomu Oguro; Eliza Y S Kimura; Alberto Orfao
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

3.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

4.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.

Authors:  Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura
Journal:  Lancet Haematol       Date:  2019-12-23       Impact factor: 18.959

5.  Characterization of the phenotype of human eosinophils and their progenitors in the bone marrow of healthy individuals.

Authors:  Marwan Hassani; Selma van Staveren; Erinke van Grinsven; Marije Bartels; Kiki Tesselaar; Guus Leijte; Matthijs Kox; Peter Pickkers; Nienke Vrisekoop; Leo Koenderman
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

6.  Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Authors:  Dai Keino; Akitoshi Kinoshita; Daisuke Tomizawa; Hiroyuki Takahashi; Kohmei Ida; Hidemitsu Kurosawa; Kazutoshi Koike; Setsuo Ota; Noriyuki Iwasaki; Junya Fujimura; Yuki Yuza; Chikako Kiyotani; Shohei Yamamoto; Tomoo Osumi; Takahiro Ueda; Shinji Mochizuki; Keiichi Isoyama; Ryoji Hanada; Akio Tawa; Atsushi Manabe; Yoichi Toguchi; Akira Ohara
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

Review 7.  New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.

Authors:  Zuzana Tothova; David P Steensma; Benjamin L Ebert
Journal:  Clin Cancer Res       Date:  2013-01-17       Impact factor: 12.531

Review 8.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

9.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

10.  Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Authors:  Kiyoyuki Ogata; Matteo G Della Porta; Luca Malcovati; Cristina Picone; Norio Yokose; Akira Matsuda; Taishi Yamashita; Hideto Tamura; Junichi Tsukada; Kazuo Dan
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.